Concord Biotech commercialises Amphotericin B (API)

concord > Concord Biotech commercialises Amphotericin B (API)

A Knowledge Hub 

Concord Biotech in the News

Concord Biotech commercialises Amphotericin B (API)

Concord Biotech commercialises Amphotericin B (API).

Concord Biotech manufactures niche fermentation based Biotechnology company, manufacturing. API’s across various therapeutics segment like Immunosuppressants, Oncology, Anti-infective & antifungals and supplies to global pharmaceutical companies.

LINK: https://www.linkedin.com/posts/concord-biotech-limited_concordbiotech-pharma-healthcare-activity-6820358951478132736-ek4_?utm_source=linkedin_share&utm_medium=member_desktop_web

11